• Home

  • About Us

    • Overview

    • Culture

    • Team

  • Drug R & D

    • Fields

    • Indications

    • Pipeline

  • Technology Platform

    • Biotechnology Platform

    • Chemistry Service

  • News Center

    • Company News

    • Industry News

  • Join Us

    • Team Building

    • Career Development

  • Contact Us

CN
EN
About BroadenBio

About BroadenBio

——

Team

图片名称

Team

Core Team

Consultant

 

On July 1, 2019, after being reviewed by the Zhongguancun Science and Technology Park Management Committee, BroadenBio Co., Ltd. was awarded the "Zhongguancun High-tech Enterprise" certification. This marks the recognition of the R&D strength and innovation ability of BroadenBio.

Founded by senior scientists and managers in the pharmaceutical industry in 2018, BroadenBio has established an enthusiastic and professional team, covers various aspects of the industry chain.

With in-depth knowledge in immunology, BroadenBio is active in exploring the fields of immuno-oncology and autoimmune diseases, through independent research and international collaboration. It is our vision to develop new drugs for the treatment of related diseases, and to let immunotherapy benefit the majority of patients.

previous page

BroadenBio Invested by KaiYuan HongDao Fund

BroadenBio Received Investment from Lapam Capital

next page

previous page

BroadenBio Invested by KaiYuan HongDao Fund

next page

BroadenBio Received Investment from Lapam Capital

address:

A1-602, 88 Kechuang 6th Street, BDA, Beijing 100176

phone:

010-58222729

e-mail:

hr@broadenbio.com

 

Copyright ©2019 BroadenBio

SEO

Powered by www.300.cn

business license